论文部分内容阅读
目的分析超声下经阴道注射MTX治疗异位妊娠的临床效果。方法选取我院2013年5月~2014年5月间收治的胎心搏动异位妊娠患者40例,作为观察组,另外选取40例无胎心搏动异位妊娠,作为对照组。其中,对照组实施全身治疗肌肉注射MTX,而观察组则在超声下经阴道局部注射MTX并结合全身用药,对比两组患者的治疗疗效。结果对照组和观察组治疗效果无明显差异P>0.05,观察组治疗前,其血HCG比对照组要高,差异具有统计学意义P<0.05。结论作为新型的异位妊娠治疗方法,超声下经阴道注射MTX具有良好的效果,但对于患有胎心搏动异位妊娠患者,采用超声下经阴道进行局部注射MTX,并有效结合全身用药具有较好效果。
Objective To analyze the clinical effect of transvaginal injection of MTX for ectopic pregnancy under ultrasound. Methods Forty patients with fetal heartbeat ectopic pregnancy admitted from May 2013 to May 2014 in our hospital were selected as the observation group and another 40 ectopic pregnancy without fetal heart rate were selected as the control group. Among them, the control group was treated with systemic therapy of intramuscular injection of MTX, while the observation group was transvaginal local injection of MTX combined with systemic administration under ultrasound to compare the therapeutic efficacy of the two groups of patients. Results There was no significant difference between the control group and the observation group (P> 0.05). Before treatment, the blood HCG in the observation group was higher than that in the control group, the difference was statistically significant (P <0.05). Conclusion As a new treatment method of ectopic pregnancy, transdermal injection of MTX under ultrasound has a good effect. However, transdermal injection of MTX by ultrasound in patients with fetal ectopic pregnancy is effective in combination with systemic administration Good effect.